Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sangamo Therapeutics (SGMO) Return on Assets (2016 - 2025)

Sangamo Therapeutics (SGMO) has 15 years of Return on Assets data on record, last reported at 1.17% in Q3 2025.

  • For Q3 2025, Return on Assets rose 15.0% year-over-year to 1.17%; the TTM value through Sep 2025 reached 1.17%, up 15.0%, while the annual FY2024 figure was 0.73%, 3.0% down from the prior year.
  • Return on Assets reached 1.17% in Q3 2025 per SGMO's latest filing, down from 0.69% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.14% in Q1 2021 and bottomed at 2.25% in Q2 2024.
  • Average Return on Assets over 5 years is 0.76%, with a median of 0.52% recorded in 2023.
  • Peak YoY movement for Return on Assets: crashed -198bps in 2024, then soared 156bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.24% in 2021, then tumbled by -39bps to 0.33% in 2022, then crashed by -303bps to 1.34% in 2023, then soared by 31bps to 0.92% in 2024, then fell by -27bps to 1.17% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 1.17% in Q3 2025, 0.69% in Q2 2025, and 0.85% in Q1 2025.